These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Comparative changes in PaO2 in moderately hypoxemic COPD patients treated with almitrine versus placebo for one year]. Górecka D; Sliwinski P; Palasiewicz G; Pachocki R; Zielinski J; Rev Mal Respir; 2001 Sep; 18(4 Pt 2):S15-7. PubMed ID: 11787328 [No Abstract] [Full Text] [Related]
23. Airway disease: the use of large animal models for drug discovery. Van der Velden J; Snibson KJ Pulm Pharmacol Ther; 2011 Oct; 24(5):525-32. PubMed ID: 21356324 [TBL] [Abstract][Full Text] [Related]
24. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. Nakawah MO; Hawkins C; Barbandi F J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163 [TBL] [Abstract][Full Text] [Related]
25. [New GOLD guidelines for the therapy of COPD]. Hausen T Pneumologie; 2012 Dec; 66(12):768. PubMed ID: 23225409 [No Abstract] [Full Text] [Related]
26. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma? Beeh KM; Beier J Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851 [TBL] [Abstract][Full Text] [Related]
27. The global burden of chronic respiratory disease in adults. Burney P; Jarvis D; Perez-Padilla R Int J Tuberc Lung Dis; 2015 Jan; 19(1):10-20. PubMed ID: 25519785 [TBL] [Abstract][Full Text] [Related]
28. Drug Development for Asthma and COPD: A Regulatory Perspective. Mann M; Meyer RJ Respir Care; 2018 Jun; 63(6):797-817. PubMed ID: 29794212 [TBL] [Abstract][Full Text] [Related]
29. The transient receptor potential vanilloid 1: role in airway inflammation and disease. Geppetti P; Materazzi S; Nicoletti P Eur J Pharmacol; 2006 Mar; 533(1-3):207-14. PubMed ID: 16464449 [TBL] [Abstract][Full Text] [Related]
30. Breaking down barriers to lung health. Barnes PJ; Ward B; Barry M Lancet Respir Med; 2014 Sep; 2(9):687-9. PubMed ID: 25209990 [No Abstract] [Full Text] [Related]
31. [What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?]. Kozlova LI; Aĭsanov ZR; Chuchalin AG Ter Arkh; 2005; 77(3):18-23. PubMed ID: 15881093 [TBL] [Abstract][Full Text] [Related]
32. Essential medicines for COPD and asthma in low and middle-income countries. Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK Thorax; 2014 Dec; 69(12):1149-51. PubMed ID: 24590803 [TBL] [Abstract][Full Text] [Related]
37. A flexible blueprint for the future of drug development. Barker R Lancet; 2010 Jan; 375(9712):357-9. PubMed ID: 20113813 [No Abstract] [Full Text] [Related]
38. Current and future therapies for airway mucus hypersecretion. Barnes PJ Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498 [TBL] [Abstract][Full Text] [Related]
40. The paradox of respiratory R&D, and why 'inhaled-by-design' heralds a new dawn in asthma and chronic obstructive pulmonary disease treatments. Yeadon M Future Med Chem; 2011 Oct; 3(13):1581-3. PubMed ID: 21942249 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]